J. Safra Asset Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.7K Buy
8,943
+560
+7% +$6.81K ﹤0.01% 251
2026
Q1
$117K Buy
8,383
+241
+3% +$3.38K 0.01% 238
2025
Q4
$117K Buy
8,142
+741
+10% +$11.1K 0.01% 242
2025
Q3
$118K Buy
7,401
+3,955
+115% +$65.1K 0.01% 195
2025
Q2
$61K Buy
+3,446
New +$67.1K ﹤0.01% 196

Other funds holding BTAL

J. Safra Asset Management's BTAL Position: Q2 2026 in Review

J. Safra Asset Management increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 6.7% in Q2 2026, buying an estimated $6.81K and bringing the position to 8,943 shares worth $99.7K. The position accounts for ﹤0.01% of the portfolio, ranked #251.

J. Safra Asset Management first reported a position in BTAL in Q2 2025 and has held it in 5 quarters since. The position peaked at $118K in Q3 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • J. Safra Asset Management held 8,943 shares of AGF US Market Neutral Anti-Beta Fund worth $99.7K as of Q2 2026.
  • J. Safra Asset Management bought 560 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $6.81K.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #251 holding.
  • J. Safra Asset Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and has held it in 5 quarters since.
  • J. Safra Asset Management's AGF US Market Neutral Anti-Beta Fund position peaked at $118K in Q3 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.